COMMUNIQUÉS West-GlobeNewswire

-
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit – United for Progress: A New Chapter in Sarcoidosis
05/06/2025 -
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
05/06/2025 -
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
05/06/2025 -
Lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant de près de 5 millions d’euros
04/06/2025 -
Launch of a capital increase with preferential subscription rights for nearly 5 million euros
04/06/2025 -
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics
04/06/2025 -
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
04/06/2025 -
Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune Diseases
04/06/2025 -
NurExone Strengthens Path to Clinical Trials for ExoPTEN with New Manufacturing Process Validation
04/06/2025 -
RAPT Therapeutics to Participate in Upcoming Investor Conferences
04/06/2025 -
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
04/06/2025 -
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
04/06/2025 -
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
04/06/2025 -
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
04/06/2025 -
Finish Healing First: Ekol Hospitals Urges Medical Travellers to Stay Until Fully Cleared
04/06/2025 -
Multiview Financial Software receives HFMA Peer Review designation
04/06/2025 -
ALK participates at Jefferies Global Healthcare Conference 2025 in New York
04/06/2025 -
Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision
04/06/2025 -
Severe Allergic Reactions post Vaccination Discussed in Journal of American Physicians and Surgeons
04/06/2025
Pages